Skip to main content

Table 4 Investigations at initial and follow-up visits (efficacy population)

From: Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI)

Investigations

Visits

Initial

1st follow-up

2nd follow-up

Last

n

(%)

n

(%)

n

(%)

n

(%)

Patient’s condition

        

  Total patients

2152

(100.0)

2139

(100.0)

1824

(100.0)

2139

(100.0)

  Missing

2

(0.1)

5

(0.2)

7

(0.4)

9

(0.4)

  Good

65

(3.0)

713

(33.3)

1349

(74.0)

1549

(72.4)

  Fair

619

(28.8)

1230

(57.5)

439

(24.1)

539

(25.2)

  Serious

1385

(64.4)

176

(8.2)

21

(1.2)

31

(1.4)

  Critical

81

(3.8)

15

(0.7)

8

(0.4)

11

(0.5)

Severity of infection

        

  Total patients

2152

(100.0)

2139

(100.0)

1824

(100.0)

2139

(100.0)

  Missing

2

(0.1)

5

(0.2)

14

(0.8)

15

(0.7)

  No infection

0

(-)

339

(15.8)

1482

(81.3)

1670

(78.1)

  Mild

174

(8.1)

1174

(54.9)

277

(15.2)

373

(17.4)

  Moderate

1378

(64.0)

565

(26.4)

32

(1.8)

54

(2.5)

  Severe

598

(27.8)

56

(2.6)

19

(1.0)

27

(1.3)

Dyspnea

        

  Total patients

2152

(100.0)

2139

(100.0)

1824

(100.0)

2139

(100.0)

  Missing

7

(0.3)

13

(0.6)

12

(0.7)

15

(0.7)

  None

283

(13.2)

932

(43.6)

1488

(81.6)

1679

(78.5)

  Mild

546

(25.4)

896

(41.9)

279

(15.3)

381

(17.8)

  Moderate

959

(44.6)

269

(12.6)

32

(1.8)

46

(2.2)

  Severe

357

(16.6)

29

(1.4)

13

(0.7)

18

(0.8)

Cough

        

  Total patients

2152

(100.0)

2139

(100.0)

1824

(100.0)

2139

(100.0)

  Missing

6

(0.3)

7

(0.3)

11

(0.6)

11

(0.5)

  None

49

(2.3)

335

(15.7)

1067

(58.5)

1177

(55.0)

  Mild

321

(14.9)

1115

(52.1)

672

(36.8)

850

(39.7)

  Moderate

1142

(53.1)

638

(29.8)

70

(3.8)

93

(4.3)

  Severe

634

(29.5)

44

(2.1)

4

(0.2)

8

(0.4)

Sputum character

        

  Total patients

2152

(100.0)

2139

(100.0)

1824

(100.0)

2139

(100.0)

  Missing

4

(0.2)

8

(0.4)

12

(0.7)

13

(0.6)

  None

338

(15.7)

582

(27.2)

1202

(65.9)

1344

(62.8)

  Clear

151

(7.0)

713

(33.3)

489

(26.8)

602

(28.1)

  Mucoid

783

(36.4)

713

(33.3)

110

(6.0)

161

(7.5)

  Purulent

876

(40.7)

123

(5.8)

11

(0.6)

19

(0.9)

Thoracic pain

        

  Total patients

2152

(100.0)

2139

(100.0)

1824

(100.0)

2139

(100.0)

  Missing

11

(0.5)

18

(0.8)

15

(0.8)

18

(0.8)

  None

696

(32.3)

1416

(66.2)

1686

(92.4)

1918

(89.7)

  Mild

554

(25.7)

539

(25.2)

98

(5.4)

166

(7.8)

  Moderate

775

(36.0)

154

(7.2)

21

(1.2)

31

(1.4)

  Severe

116

(5.4)

12

(0.6)

4

(0.2)

6

(0.3)

Auscultation

        

  Total patients

2152

(100.0)

2139

(100.0)

1824

(100.0)

2139

(100.0)

  Missing

27

(1.3)

74

(3.5)

48

(2.6)

63

(2.9)

  Normal

84

(3.9)

794

(37.1)

1591

(87.2)

1821

(85.1)

  Pathological

2041

(94.8)

1271

(59.4)

185

(10.1)

255

(11.9)

Core temperature*

        

  Total patients

2152

(100.0)

2139

(100.0)

1824

(100.0)

2139

(100.0)

  Missing

30

(1.4)

93

(4.3)

156

(8.6)

187

(8.7)

  Low

0

(-)

1

(<0.1)

0

(-)

0

(-)

  Normal

77

(3.6)

552

(25.8)

628

(34.4)

724

(33.8)

  Mild

147

(6.8)

848

(39.6)

936

(51.3)

1052

(49.2)

  Moderate

531

(24.7)

585

(27.3)

93

(5.1)

159

(7.4)

  Severe

1367

(63.5)

60

(2.8)

11

(0.6)

17

(0.8)

Chest radiography**

        

  Total patients

2152

(100.0)

2139

(100.0)

1824

(100.0)

2139

(100.0)

  Missing

14

(0.7)

51

(2.4)

16

(0.9)

31

(1.4)

  Not done

8

(0.4)

1230

(57.5)

397

(21.8)

483

(22.6)

  Normal

16

(0.7)

292

(13.7)

1178

(64.6)

1299

(60.7)

  Pleural effusion

144

(6.7)

41

(1.9)

24

(1.3)

27

(1.3)

  Unilateral infiltrate

1635

(76.0)

425

(19.9)

178

(9.8)

263

(12.3)

  Bilateral infiltrate

427

(19.8)

114

(5.3)

34

(1.9)

41

(1.9)

  Multilobar involvement

92

(4.3)

18

(0.8)

11

(0.6)

12

(0.6)

  1. *Comparison of temperature ranges: Low: <36.0°C, Normal: 36.0°C – <37.5°C, Mild: 37.5°C – <38.0°C, Moderate: 38.0°C – <39.0°C, Severe: ≥39.0°C; **Multiple responses.